The immunobiology of cancer immunosurveillance and immunoediting.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing preclinical mechanisms and correlative data without primary clinical trial data
PubMed 15308095 · doi:10.1016/j.immuni.2004.07.017
What was done
This narrative review synthesizes research from murine tumor models and correlative human cancer studies regarding cancer immunosurveillance and the broader framework of cancer immunoediting.
What was found
The abstract reports no numerical metrics or quantitative effect sizes. It details the conceptual structure of cancer immunoediting, defined by three progressive phases: elimination (host protection and surveillance against primary nonviral tumors), equilibrium (dormancy and immune-mediated tumor sculpting), and escape (outgrowth of tumor variants resistant to immune detection or destruction).
Why it matters
This framework formalized how the immune system acts as both a tumor suppressor and a selective force shaping tumor immunogenicity, laying a theoretical foundation for modern cancer immunotherapy strategies.
Limits
The abstract describes a narrative conceptual review with no specific sample sizes, statistical measures, or systematic search protocols. The summarized evidence is largely derived from experimental mouse models and correlative human data, limiting direct clinical certainty.
Cited by
- supports Every person has cancer cells continuously present in their body that the immune system constantly destroys.